Suvorexant, a Dual Orexin Receptor Antagonist for the Management of Insomnia

Documenti analoghi

• Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
  di: Andrew H. Han, et al.
  Pubblicazione: (2023-01-01)
• Suvorexant: The first orexin receptor antagonist to treat insomnia
  di: Dubey, Ashok K., et al.
  Pubblicazione: (2015)
• Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
  di: Norman, Jessica L, et al.
  Pubblicazione: (2016)
• Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine
  di: Gentile, Taylor A, et al.
  Pubblicazione: (2018)
• Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects
  di: Ma, Junshui, et al.
  Pubblicazione: (2014)